Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

May 25, 2022
BioUtah News
bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel

Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® Joint Infection (JI) Panel has received De Novo authorization from the US Food and Drug Administration (FDA). This panel tests for 31 pathogens implicated in most acute joint infections, and also includes 8 antimicrobial resistance (AMR) […]

May 18, 2022
BioUtah News
PolarityTE to Effectuate 1-for-25 Reverse Stock Split

PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock.

May 16, 2022
BioUtah News
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update

PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.

May 16, 2022
BioUtah News
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. 

May 12, 2022
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
BioHive Takes the Stage at One Utah Summit

The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand America Hotel in Salt Lake City. Speakers from the life sciences industry addressed the crowd on topics ranging from job creation and talent development to life-saving innovation and drug discovery. Tom Polen, CEO of BD, and Rob […]

May 12, 2022
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
Recursion Co-Founder and CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award during the summit’s special recognition ceremony. The prestigious award commends the distinguished service, significant achievement, and positive economic impact of individuals to the state […]

May 12, 2022
BioUtah News
Recursion CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award which recognizes the distinguished service, significant achievement, and positive economic impact of individuals to the state of Utah and beyond in the fields of science and […]

May 11, 2022
BioUtah News
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

May 11, 2022
BioUtah News
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment

RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB.

May 11, 2022
BioUtah News
New Executive Appointments Position ARUP Laboratories for Future Growth

New Executive Appointments Position ARUP Laboratories for Future Growth

May 11, 2022
BioUtah News
First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIATM biopolymer surgical aortic heart valve.

May 5, 2022
Policy News
E&C Leaders Unveil FDA User Fees Legislative Package

Bipartisan Agreement Will Support Innovation, Lower Costs, and Improve People’s Lives Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), Ranking Member Cathy McMorris Rodgers (R-WA), Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), and Health Subcommittee Ranking Member Brett Guthrie (R-KY) today unveiled a comprehensive legislative package to reauthorize the Food and Drug […]

May 5, 2022
BioUtah News
Biomerics Announces Image Guided Intervention (IGI) Division

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

May 5, 2022
BioUtah News
Genovac Acquires Platform for Antibody Screening and Characterization Services

Genovac announces that the company has acquired Carterra’s LSA platform for use in its discovery services. Genovac, previously a part of Aldevron before a management buyout in 2020, has been providing discovery services to life science researchers since 1999 from its site in Freiburg, Germany. More recently, Genovac added production, characterization, and cell line development […]

May 5, 2022
BioUtah News
CoNextions TR Tendon Repair System receives FDA clearance

Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm CoNextions Inc., an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in […]

May 5, 2022
BioUtah News
Blackrock Neurotech and Phantom Neuro Partner to Enable Prosthetics and Exoskeletons that Mimic Human Movement in Real-Time

The Phantom X system uses muscle-sensing implant technology to enable greater mobility in people with orthopedic injuries. SALT LAKE CITY and AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Blackrock Neurotech, an  industry leader in brain-computer interface (BCI) technology, and Phantom Neuro, a recently launched neurotech startup that delivers a high accuracy system for lifelike control of robotic […]

May 5, 2022
BioUtah News
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively Ended the quarter with $339.2 million in cash, […]

May 5, 2022
BioUtah News
BD REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULT

FRANKLIN LAKES, N.J., May 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal year 2022, which ended March 31, 2022. Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of […]

May 5, 2022
BioUtah News
BD Announces Inaugural Members of Scientific Advisory Board

Scientific Advisory Board Will Review Company Innovation Pipeline and Advise on Emerging Trends in Health Care, Science and Technology FRANKLIN LAKES, N.J., May 2, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the inaugural members of the BD Scientific Advisory Board (SAB), which is comprised […]

May 5, 2022
BioUtah News
Cibus Biotechnologies Celebrates a New Home, New Name

The innovation blooming in Utah’s BioHive was on full display Wednesday at a ribbon-cutting ceremony announcing a new home and new name for Cibus Biotechnologies. Under the new name, Seek Labs, the company has moved to a new location at Salt Lake City’s Northgate. The new location offers expanded laboratory facilities and room to grow. […]

May 4, 2022
BioUtah News
BioMérieux Joint Infection Panel Gets FDA De Novo Authorization

BioMérieux said on Wednesday that its BioFire Joint Infection (JI) Panel has received de novo authorization from the US Food and Drug Administration. 

May 4, 2022
BioUtah News
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers

SALT LAKE CITY, May 3, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) today announced the enrollment of the first subject in the Phase III pivotal study evaluating SkinTE in the investigational use of treatment of Wagner grade 2 diabetic foot ulcers (DFUs), entitled “Closure Obtained with Vascularized Epithelial Regeneration for DFUs with SkinTE,” or “COVER […]

May 4, 2022
BioUtah News
CenExel Acquires iResearch

Premier CNS-Focused Research Facilities in Georgia Join the CenExel Centers of Excellence Clinical Research Site Network

April 28, 2022
BioUtah News
BioUtah Remembers Senator Orrin Hatch

Senator Orrin Hatch, who served 42 years in the Senate and is the longest serving Senator in Utah’s history, died at 88 last Saturday. He is remembered fondly by Utah’s life sciences industry as a stalwart champion for medical innovation and improving the lives of patients. Reflecting on the Senator’s life and legacy, Kelvyn Cullimore, […]